Xdator 300 Tablet contains Ursodeoxycholic Acid 300mg, a hydrophilic bile acid used primarily in the treatment of certain liver and gallbladder disorders. Ursodeoxycholic Acid acts by reducing cholesterol absorption and dissolving cholesterol-rich gallstones, thereby improving bile flow and protecting hepatocytes from toxic bile acids. It is indicated for the management of primary biliary cholangitis, dissolution of radiolucent gallstones in patients who are not candidates for surgery, and as adjunctive therapy in certain cholestatic liver diseases. The mechanism involves altering the bile acid composition, reducing cholesterol saturation in bile, and exerting cytoprotective, anti-inflammatory, and immunomodulatory effects on liver cells. Xdator 300 is administered orally, with dosage tailored according to the specific condition and patient response, typically ranging from 10 to 15 mg/kg/day divided into two or three doses. It is contraindicated in patients with complete biliary obstruction, acute cholecystitis, or hypersensitivity to Ursodeoxycholic Acid. Common adverse effects include gastrointestinal disturbances such as diarrhea, nausea, and abdominal discomfort. Regular monitoring of liver function tests is recommended during therapy to assess efficacy and detect potential hepatotoxicity. Xdator 300 should be used under medical supervision to ensure safe and effective treatment outcomes.